Related Experiment Videos
HIV-1 integrase inhibitors: past, present, and future
N Neamati1, C Marchand, Y Pommier
1Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland 20892, USA.
Advances in Pharmacology (San Diego, Calif.)
|October 3, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice.
bioRxiv : the preprint server for biology·2024
Rationalisation of the purification process for a phage active pharmaceutical ingredient.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2024
Maintaining the knowledge and neonatal resuscitation skills of student midwives 6 months after an educational program.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.
Nature communications·2019
A descriptive study of advising practices during travel health consultations in France.
Journal of travel medicine·2017
Assessing toxicity of metal contaminated soil from glassworks sites with a battery of biotests.
The Science of the total environment·2017
T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.
Advances in pharmacology (San Diego, Calif.)·2026
Tracking therapeutic T cells in vivo.
Advances in pharmacology (San Diego, Calif.)·2026
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.
Advances in pharmacology (San Diego, Calif.)·2026
Transient T cell therapies.
Advances in pharmacology (San Diego, Calif.)·2026
Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.
Advances in pharmacology (San Diego, Calif.)·2026
Engineering T cell metabolism to enhance therapeutic efficacy.
Advances in pharmacology (San Diego, Calif.)·2026
IL-15 aggravates cardiac ischemic injury via impairing macrophage efferocytosis and driving inflammation.
Journal of Zhejiang University. Science. B·2026
Analysis of Antimicrobial Prescribing Patterns and Resistance Trends in Intensive Care Units.
Journal of pharmacy & bioallied sciences·2026
Myocardial immune vulnerability unmasked after treatment with immune checkpoint inhibitors: a case report.
European heart journal. Case reports·2026
Immunohistochemical expression of D2-40 biomarker in the diagnosis of gingival lymphangioma: A case report of a geriatric patient.
Journal of Indian Society of Periodontology·2026
Immunogenetics and TCR expression patterns together predict future T1D onset from multi-omic datasets.
Frontiers in genetics·2026